Plasmodium berghei Circumvents Immune Responses Induced by Merozoite Surface Protein 1- and Apical Membrane Antigen 1-Based Vaccines

Functional immunogenicity of baculovirus expressing Pfs25, a human malaria transmission-blocking vaccine candidate antigen

(2010) Godfree Mlambo et al.   VACCINE

Baculovirus-Based Nasal Drop Vaccine Confers Complete Protection against Malaria by Natural Boosting of Vaccine-Induced Antibodies in Mice

(2009) S. Yoshida et al.   INFECTION AND IMMUNITY

Growth-Inhibitory Antibodies Are Not Necessary for Protective Immunity to Malaria Infection

(2009) E. E. H. Murhandarwati et al.   INFECTION AND IMMUNITY

Construction of Transgenic Plasmodium berghei as a Model for Evaluation of Blood-Stage Vaccine Candidate of Plasmodium falciparum Chimeric Protein 2.9

(2009) Yi Cao et al.   PLoS One

Murine Model for Assessment of Plasmodium falciparum Transmission-Blocking Vaccine Using Transgenic Plasmodium berghei Parasites Expressing the Target Antigen Pfs25

(2008) G. Mlambo et al.   INFECTION AND IMMUNITY

Protection Induced by Plasmodium falciparum MSP142 Is Strain-Specific, Antigen and Adjuvant Dependent, and Correlates with Antibody Responses

(2008) Jeffrey A. Lyon et al.   PLoS One

Comparison of immunogenicity of five MSP1-based malaria vaccine candidate antigens in rabbits

(2008) Zarifah Hussain Reed et al.   VACCINE